Proinsulin peptide/calcitriol liposomes(Uniquest)

N/A

Report date: 2024/10/29 16:23:28

Base Information

Drug NameProinsulin peptide/calcitriol liposomes(Uniquest)
Drug Alias NameProinsulin peptide/calcitriol liposomesASITI-201
ClassificationBiologics
Mechanisms of ActionVitamin D receptor agonistsVitamin D analoguesInsulin receptor agonists
TargetsVitamin D receptorInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsYes CalcitriolRecobinant human proinsulin C peptide (Shanghai Newsummit/Shanghai Yizhong)
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniquest Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniquest Pty Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A